Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Selective binding of glutathione conjugates of fatty acid derivatives by plant glutathione transferases
Introduction: Introduction: AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 177191) engineered to replicate hGHs fat-metabolism effects without altering IGF-1 or glucose levels. In preclinical research, it promoted lipolysis (fat breakdown) and reduced lipogenesis (fat storage) through receptor-independent mechanisms. AOD-9604 Fast Facts Class: Synthetic hGH fragment analog (Tyr-hGH 177191) Intended purpose: Stimulate fat metabolism while avoiding hGHs growth or glucose effects Mechanism: Increases fat oxidation, enhances lipolysis, suppresses lipogenesis Distinct from hGH: Does not activate the growth hormone receptor or raise IGF-1 Development stage: Completed Phase II trials
6.6% of non-users In other words, GLP-1 medications were associated with: ~30% higher risk of osteoporosis ~12% higher risk of gout These results do not prove the medications directly cause the conditions , but they suggest a possible relationship worth further investigation
Expanding clinical implications to complex human behavioral and somatic disorders
Replicated blood-based biomarkers for myalgic encephalomyelitis not explicable by inactivity
